Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.−14C>T mutation in all patients. Issue 1 (13th December 2012)

• Record Type: Journal Article
• Authors: Rauch, Frank; Moffatt, Pierre; Cheung, Moira; Roughley, Peter; Lalic, Liljana; Lund, Allan M; Ramirez, Norman; Fahiminiya, Somayyeh; Majewski, Jacek; Glorieux, Francis H
• Is Part Of: Journal of medical genetics. Volume 50:Issue 1(2013)
• Page Start: 21
• Page End: 24
• Publication Date: 2012-12-13
• Subjects: Calcium and bone; Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmedgenet-2012-101307
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Background: Osteogenesis imperfecta (OI) type V is an autosomal dominant bone fragility disorder that we had described a decade ago. Recent research has shown that OI type V is caused by a recurrent c.-14C>T mutation in IFITM5 . In the present study, we assessed all patients diagnosed with OI type V at our institutions for the presence of the IFITM5 mutation. Methods: IFITM5 exon 1 was analysed by Sanger sequencing in genomic DNA from 42 patients with OI type V (age: 2–67 years; 18 female). Results: The c.−14C>T mutation of IFITM5 was detected in all individuals. Indicators of disease severity varied widely: Height z-scores (n=38) ranged from −8.7 to −0.1, median −3.5. Median final height was 147 cm in men (N=15) and 145 cm in women (N=10). Lumbar spine areal bone mineral density z-scores in the absence of bisphosphonate treatment (n=29) were between −7.7 and −0.7, median −5.3. Scoliosis was present in 57%, vertebral compression fractures in 90% of patients. Conclusions: Even though the disease-causing mutation is identical among patients with OI type V, the interindividual phenotypic variability is considerable.